Insider Transactions in Q1 2023 at Neuro Pace Inc (NPCE)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2023
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,167
-6.07%
|
$20,668
$4.1 P/Share
|
|
Mar 03
2023
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,019
-2.66%
|
$16,076
$4.1 P/Share
|
|
Feb 21
2023
|
Michael Favet Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
225,000
+35.6%
|
-
|
|
Feb 20
2023
|
Irina Ridley Chief Legal Officer/Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+36.18%
|
-
|
|
Feb 20
2023
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+36.41%
|
-
|
|
Feb 20
2023
|
Martha Morrell CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+36.84%
|
-
|
|
Jan 22
2023
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
264
-0.31%
|
$528
$2.98 P/Share
|
|
Jan 22
2023
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
212
-0.14%
|
$424
$2.98 P/Share
|